Viewing StudyNCT00111007



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00111007
Status: COMPLETED
Last Update Posted: 2014-10-31
First Post: 2005-05-16

Brief Title: A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
Sponsor:
Organization: Bayer